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Objectives.Thisstudysoughttodeterminethecirculatinglevels
of eytokinesand their respectiveendogenousmodulatorsin
patientswithcongestiveheartfailureof variableseverily.
Background.Activationof immuneelementsIoealizedin the
heartor peiiphery,or both,maypromotereleaseof eytokinesin
patientswith congestiveheart failure.Ai@ougban increased
circulatinglevelof tumornecrosisfactor-alpha(TNF-aIpha)and
its solublereceptortypeII (sTNF-RH)is wdidoc~enti!d, less is
knownaboutothereytokines(i.e.,interleukih-1-be@IIL1-beta],
interleukin-6[IL6] and interleukin-2[IL2] and their soluble
reeeptor/ie.ceptorantagonists).
Metlrudv.Circulatinglevelsof TNF@phaand sTNF-U ILl-




arterydiseaseor hypertension.The severityof their symptoms,
whichrangedfromNewYorkHeartAssociationfunctionalclassI
to IV,was confirmedbymeasurementof peakoxygenconsump-
tion.
Resruls.The percentageof patientswith elevatedlevels of
eytokinesand theircorrespondingsolublereeeptorheceptoran-
tagonistssignificantlyincreasedwithfunctionalclass.ForTNF-









these patients,circulatinglevels of sTNF-RHand IL1.Ra are
moresensitivemarkersof immuneactivationthanareciretiating
levelsofTNF-aiphandIL1-beta,respectively.LevelsoffL2 and
IL2.sR arenot eleva@dwhencongestiveheartfailureis due”to
coronaryarterydiseaseor hypertension.
(JA COUCardwl 1996;28:964-71)
The circulatinglevelsof tumor necrosisfactor-alpha(TNF-
alpha)and other cytokines,suchas interleukin-l-beta(IL-l-
beta),interleukin6 (IL6) and interleukin2 (IL-2),havebeen
reported to be increasedin patientswith congestiveheart
failure(l-9). However,ejtokinelevelsdo not appear to be
increasedthroughouthesyndromeofcongestiveheartfailure;
onlythe mostsymptomaticpatientsconsistentlyhaveelevated
levelsof cytokines(1,3,9).Of interestwith regard to TNF-
alpha,Ferrariet al.(10)recentlyreportedthatactivationofthe
TNFsystemisbestassessedbymeasuringcirculatinglevelsof
the shedded extracellulardomain of its type II receptor,
sTNF-RII,rather than the TNF-alphalevels,Much less is
l&ownaboutthe levelsof the respectiveendogenousoluble
modulatorsofothercytokinesinpatientswithcongestiveheart
failure. Accordingly,the present study was undertaken to
characterizethe patternofcytokineactivationin patientswith
congestiveheart failure.Circulatinglevelsof TNF-alpha,IL
l-beta, IL6 and IL2 and their respectiveendogenousmodu-
lators, sTNF-RII,IL1 receptor antagonist(IL1-Ra), IL6
solublereceptor (IL6-sR) and IL-2 solublereceptor-alpha
(IL-2-sR-alpha)weremeasuredin ambulatorypatientswhose
symptomsranged from New York Heart Associationfunc-
tionalclassI to IV.Theetiologyofcongestiveheartfailurewas
limitedto coronaryarterydiseaseand systemichypertension.










Study group. Eighty ambulatorypatients (58 men, 22
women)with congestivehe@”’failuredue to ischemicor
hypertensivecardiomyopathywere studied.All patientshad






















patients and age-matchednormal subjectsperformed two
symptom-limitedexercisetreadmilltests usingthe modified
Naughtonprotocolwithan intervalof3 to 7days.Exercisewas
limitedby symptomsof fatigueor dyspnea,or both, in all
patients.Noneofthemexperiencedanginapectorisduringthe
treadmillexercisetests. Oxygenuptake and carbon dioxide
productionwere measuredcontinuouslyduring exerciseby
meansof a breath-by-breathanalysisof expiredgases(CPX
MetabolicCart, Medical Graphics),which was calibrated
within1 h of testing.Peak oxygenconsumption(Voz [ml/kg
body weightper rein]) was determinedfrom the maximal
oxygenuptakeattainedduringthe final30s of exercise,when
the respiratoryexchangeratiowas>1.0.Whenthe twodeter-
minationsofpeakV02werewithin10%,the highestvaluewas
reported.Whenthe two determinationsdifferedby >10%, a
symptom-limitedexercisetestwasrepeateduntilthiscriterion
wasmet and the highestvaluewasreported.
Cytokinemeasurements.Sixteenmillilitersof blood was




Concentrationsof cytokinesand their respectivesoluble
receptor/receptorantagonistswere measuredusingcommer-
cialenzyme-linkedimmunosorbentassay(ELISA)kits(Quan-
tikine,R&D Systems)accordingto the manufacturer’speci-
fications,A highsensitivitykit(QuantikineHS,R&DSystems)







the studyfor diagnosticpurposes.The severityof congestive
heartfailurerangedfromfunctionalclassI to IV.Patientswith
significantconcomitantdiseasessuchas infections,renal fail-
ure, cancer and autoimmunediseasewere excluded.The
presenceof cardiaccachexiawasalsoa criterionof exclusion.
Cardiaccachexiawasdefinedby a bodyweightat least 15%
belowthe predictedideal weightand minimalreductionof
30%in tricepsskinfoldthicknessand midarmmusclecircum-
ference(11).Nopatientshadreceivedanti-inflammatorydrugs









































































































































IL2 = interleukin-2;IL-2-sR-alpha= interleukirr-2solublereceptor-alpha;




All sampleswere run-induplicates;the averagevalueof the
twomeasurementsis reported.The linearrangeof eachassay
andthevalueusedto definean elevatedplasmaconcentration
for each eytokineand its correspondingsolublereceptor/
receptorantagonistare showninTable2.Cytokinesor soluble
receptor/receptorantagonistswere consideredelevatedwhen
their levelswere abovethe 95thpercentilefor controlvalues
(R&D Systems).Circulatinglevelsof eytokinesand their
respectivesoluble modulatorswere measured in 20 age-
matchednormalsubjects(13men,7women)whosemeanage
andpeakV02were58.2* 7.3yearsand 30.1t 7.2ml/kgper
rein,respectively.All age-matchednormalsubjectshad circu-
latinglevelsofcytokinesandtheirrespectivesolublereceptors/
receptor antagonistsbelow the 95th percentileof control
values.
Statistical analysis. Mean age, left ventricularejection
fractionandpeakV02byfunctionalclasswerecomparedusing
one-wayanalysisof variance.Bloodurea nitrogenand creati-





analyzedusingthe Mantel-Haenszeltest for lineartrend.
Summarystatisticsarepresentedasthemeanvaluef 1SD
and percentages.A p value<0.05wasconsideredsignificant.
Results
Cytoldnesand their endogenousmodulatorsin relationto
functionalclass. Individualdata for circulatinglevelsof eyto-
kinesand their respectiveendogenousmodulatorsare shown
in Figures1A,2A,3Aand4.Thepercentagesofpatientswith
elevatedcirculatinglevelsof eytokinesand their respective
endogenousmodulatorsare shownin FiguresIB, 2Band 3B.
Circulatinglevelsof TNF-aJphawerewithinnormalrangein
mostpatientsin functionalclassesI andII, althoughtheywere
elevatedin 25Y0and 4270of patientsin functionalclassesIII
andIV,respectively(Fig.1A,B).Similarly,circulatinglevelsof
sTNF-RII were within normal range in most patients in
functionalclassesI andII, althoughtheywereelevatedin 55%
and 9290of patientsin functionalclassesIII and IV, respec-
tively(Fig.1A,B). The percentageof patientswithabnormal
TNF-alphaandsTNF-RIIincreasedwithfunctionalclass(p <
0.007and p <0.001, respectively)(Fig.IB).
Circulatinglevelsof IL-l-betawerein the normalrangein
allbut onepatientin functionalclassesI andII, althoughthey
wereelevatedin25Y0and37Y0ofpatientsinfunctionalclasses
III and IV, respectively(Fig. 2A, B). The percentagesof
patientswith elevatedIL-1-Ralevelswere 19%and 25% in
functionalclassesI and II, respectively,and 45%and 65%in
functionalclassesIII and IV, respectively(Fig. 2A, B). As
detectedwith TNF-alphaand sTNF-RII,the percentageof
patientswithabnormalIL-l-betaand IL-1-Raincreasedwith
functionalclass(p <0.001 and p <0.002, respectively)(Fig.
2B).
Circulatinglevelsof IL-6were normalin the majorityof
patientsin functionalclassesI, II andIII andwereelevatedin
58%ofpatientsinfunctionalclassIV (Fig.3A,B).Circulating
levelsof IL-6-sRwerenormalin allpatientsin functionalclass
I. Theywereelevatedin 15%ofpatientsin functionalclassII,
in25’%oofpatientsinfunctionalclassIII andin34Y0ofpatients
in functionalclassIV (Fig.3A,B). Overall,the percentageof
patientswithelevatedlevelsofIL-6andIL-6SRincreasedwith
functionalclass(p <0.001 and p <0.008, respectively)(Fig.
3B).
Circulatinglevelsof IL-2werebelowthe detectablelevels
in all but two patientswith congestiveheart failure. One
patientwas in functionalclassII and the other was in func-
tionalclass111,Circulatinglevelsof IL-2-sR-alphawere nor-
malin allbut sevenpatientswithcongestiveheartfailure.Two
patientswerein functionalclassI, onewasin functionalclass
II, twowereinfunctionalclassIII andthe remainingtwowere
in functionalclassIV (Fig.4).
Renalfunctionwasreducedin patientsin functionalclass
IVwhencomparedwithpatientsin functionalclassesI, II and
III (Table 1). Nevertheless,the percentageof patientswith
abnormallevelsof sTNF-RII,IL-l-beta, IL-1-Ra,IL-6 and
IL6-sR was similarin patientswith creatininebelow and
above2mg/dl.Thepercentageofpatientswithabnormalevels
of TNF-alphawassignificantlygreaterin patientswithcreati-
nine >2 mg/dlwhen comparedwith that of patientswith
creatinine<2 mg/dl(78%vs.20%,p < 0.02).
Comparison of cytokines and their soluble receptor/
receptorantagonists. Thepercentageofpatientsinfunctional
class IV with elevatedlevelsof sTNF-RIIwas significantly
greaterthanthatofpatientswithelevatedTNF-alpha(92%vs.
42%) (p < 0.001)(Fig. IB). This differencetended to be
greateralsofor patientsin functionalclassIII (55%vs.25%)
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FigureL & IA panel,Circulatinglevelsof tumornecrosisfactor- 90.
alpha(TNF-alpha)in 80patientswithcongestiveheartfailureas a
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greaterthan that of patientswithelevatedlevelsof IL-l-beta
(63%vs.37%)(p= 0.130)(Fig.2B).
In contrast,thepercentageofpatientsinfunctionalclassIV
withelevatedlevelsof IL-6tendedto be greaterthan that of
patientswithelevatedlevelsof IL-6-sR(58%vs. 33%)(p =
0.147)(Fig.3B).
Coronaryarterydiseaseversushypertension.The number
of patientswith hypertensionwas relativelysmall(n = 30);




beta, ILRa, IL-6and IL-6-sRwasnot statisticallydilferentin
patientswithcongestiveheart failuredue to coronaryartery
diseaseor hypertension(datanot shown).
Discussion
Profile of eytokineactivation. The present data demon-
stratethat,aspreviouslynotedwithTNF-alphainpatientswith
congestiveheart failure, circulatinglevelsof IL-l-beta and
IL-6 are onlyelevatedin severelysymptomaticpatients.The
present data also confirmthat measurementof sTNF-RII
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‘oo~ Figure2. ~ Leftpanel,Circulatinglevelsof interleukin-l-beta
(IL-l-beta)in 80patientswithcongestiveheartfailureasa function




in eachtimctionalclass.Dashedhorizontalline indicatesthe 95th
percentilevaluesfornormalsubjects.Rightpanel,Circulatinglevels
of IL1 receptorantagonist(IL1-Ra)asa functionoftheseverityof
symptomsin the same80patients.Thehatchedhorizontalbar and
the dashedlinecorrespondto undetectablelevelsand95thpercen-
tile values for normal subjects,respectively.B, Percentagesof
patientswithelevatedlevelsofIL1-betaandIL1-Ra abovethe95th
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tionof thiscytokinesystemin congestiveheart failure.More-
over,ourdataextendthisobservationto IL-1,withthe IL-1-sR
antagonistbeing more elevated in a substantiallygreater
numberof patientsthan IL-1itself.In contrast,thisobserva-
tiondoesnot applyto IL-6,becauseIL-6ismoreelevatedin a
greater numberof patients than the IL-6 solublereceptor.
Last,our data indicatethat circulatinglevelsofboth IL-2and
IL2-sR-alphaarenormalwhencongestiveheartfailureresults
fromischemicor hypertensiveheartdisease.Thislastfindingis
at variancewith the elevatedIL2 levelsthat we previously
documentedin patientswith congestiveheart failuredue to
idiopathicdilated cardiomyopathy(7) and may suggesta
ditlerentmechanismfordiseaseprogression.Interleukin-2isa
productof activatedT cells,and recentdata demonstratethe
presenceof such cells in the myocardiumof patientswith
dilatedcardiomyopathy(12,13).Furthermore,elevatedlevels
of IL2-sR, an indicatorof T-cell activation,have been re-
portedin patientswithidiopathicdilatedcardiomyopathy(8).
Thus,our previousdata, as wellas data fromother laborato-





















































the numberof patientswithundetectablelevelsin each functional
class.The dashedhorizontalline correspondsto the 95thpercentile
valuesfor normalsubjects.Right panel, Circulatinglevelsof IL-6
solublereceptor(sIL-6-R)as functionof the severityof symptomsin




normalsubjectsas a functionof the severityof symptoms.
ischemicor hypertensiveheart diseasesuggeststhat activated
T cellsmaynot playa significantrolewhencongestiveheart
failureoccurssecondaryto coronaryarterydiseaseor hyper-
tension.
Site of eytokine production.The stimulusand site of




stillunclearin congestiveheart failure.Presumably,the im-
munesystemis activatedin responseto fociof injury,which
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Alternatively,Kapadiaet al. (14) and Mann et al. (15)pro-
posedthat the heart itselfmaybe an importantproducerof
eytokinesandespeciallyofTNF-alphain patientswithconges-
tiveheart failure.Althoughthe goalof the presentstudywas
not to addressthe site of activationof TNF-alphaand other
cytokinesin congestiveheart failure,our data suggestthat
peripheralrather than cardiacfociof injurymayactivatethe
immunesystemand therebyelicitcytokineproduction.Evi-






































Figure4. Left panel, Circulatinglevelsof interleukin-2[IL-2)in 80 dysfunction of increasing severity may be responsible for




representthe numberof patientswith undetectablelevelsin each
functionalclass.Allnormalsubjectshaveundetectablelevelsof IL2.
Rightpanel,Circulatinglevelsof IL-2solublereceptor-alpha(sIL-2-
R-alpha)as functionof the severityof symptomsin the same 80
patients.Thehatchedhorizontalbar and the dashedhorizontalline
correspondto undetectablelevelsand 95th percentilevalues for
normalsubjects,respectively.
Moreover,a clear disparitywas present betweenthe slight
further reductionin left ventricularejectionfraction from
classesIII and classIV (i.e., 29Y0to 2470)and the marked
increasein circulatinglevelsof cytokinesin patientsin func-
tionalclassIV. If the elevationof circulatingcytokinelevels
resultedpredominantlyfroman inflammatoryresponsewithin
theheart,onewouldexpectcirculatinglevelsofeytokinesto be





wouldnot expecta steadyelevationof cytokinesfrom func-
tional class I to IV. Thus, substantialeytokineproduction,
whichoccursat a late stageof the syndromeof congestive
heart failure,suggeststhat peripheralabnormalitiesthat cor-
relate with symptomsmay be an important stimulusfor
cytokineproduction.Alternatively,left ventriculardiastolic
eytokineproductionin the late stagesof the syndromeof
congestiveheart failure.
Cytokineactivationand etiology of heart failure. Circu-
latinglevelsof TNF-alpha,IL-l-betaand IL-6didnot appear










or dyspnea,or both, in all our patientswith ischemicheart
disease.Whetherthe presenceof anginais a prerequisitein
patientswith ischemicheart diseasefor increasedcytokine
secretionby mononuclearleukocytesis presentlyunknown.
Increasedeytokinesecretiondueto ischemicheartdiseasemay
also be modestwhen comparedwith that inducedby the
congestiveheart failureprocess,so that severelysymptomatic
patientshave similarlevelsof cytokinesindependentof the
etiologyof their heart failure(i.e., ischemicor hypertensive).
Cardiacreleaseof eytokines,whichhas been documentedin
patientswith acutemyocardialinfarctionafter percutaneous
transluminalcoronaryangioplasty,isunlikelyto haveoccurred







Cytokinesand theirmodulators. It isunclearwhycirculat-
ing levels of cytokinereceptors or antagonistsare more
elevatedina greaterpercentageofpatientsthanthecirculating
levelsof the cytokineitself.SolubleTNF-alphareceptorshave
been shownto interfere with TNF-alphawhen measuring
TNF-alphawith certain ELISA kits (17). However,such
interferencehas not been reportedwiththe assaykit that we
used(R&DSystems)(18).A differencein metabolicturnover,
renalclearance,rate of sheddingand sensitivityof assaysare
likelyto at leastpartiallyexplainthe disparitybetweencircu-
lating levels of the cytokinereceptor/receptorantagonists
(19,20).In our patients,solublereceptorsfor IL-6appearto
behavedifferentlyfromsTNF-RIIandIL-1-sRantagonists.Of
note, a negativecorrelationbetweenIL-6 and IL-6-sRhas
been reported in childrenwithjuvenilerheumatoidarthritis
and in patientswith sepsis(21,22).Thus,IL-6appearsto be
uniqueamongcytokines,becausea negativefeedbackexists
betweenIL-6and its solublereceptor.An increasedturnover
of membrane-anchoredIL-6-sRin the presenceof highlevels
of IL-6mayaccountfor the decreasedlevelsof IL-6-sR(22).
Conclusions. Thisreport supportsand extendsour previ-
ous study,aswellas the investigationsof others,suggestinga
role for immune activationin congestiveheart failure. It
demonstratesa strongcorrelationbetweenincreasedcytokine
andsolublereceptor/receptorantagonistlevelsandtheseverity
of disease.Interestingly,it alsosuggeststhat activatedT cells
maynotbeassignificanta celltypein ischemicorhypertensive
cardiomyopathyas in idiopathicdilatedcardiomyopathy.Ad-
ditional studies assessingthe contribution.of monocytes/
macrophages,as wellas cardiacand peripheralvascularele-
ments,are necessaryto clarifythe site and mechanism(s)for
immuneactivationin thischronicdiseaseprocess.
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